Damage-Associated Molecular Patterns in Hypertension
高血压损伤相关的分子模式
基本信息
- 批准号:9209298
- 负责人:
- 金额:$ 188.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-01 至 2022-01-31
- 项目状态:已结题
- 来源:
- 关键词:Adaptive Immune SystemAddressAdultAgeAnimal ModelAnimalsApoptosisAutomobile DrivingBasic ScienceBehavioralBiologyBlood CirculationBlood PressureBlood VesselsCardiovascular DiseasesCardiovascular systemCell AggregationCell DeathCellsCessation of lifeClinicalComplexDendritic CellsDevelopmentDisciplineDiseaseElementsEndothelial CellsErythrocytesEventExhibitsExperimental Animal ModelFemaleFoundationsGoalsHMGB1 ProteinHome environmentHumanHypertensionImmuneImmune systemImpairmentInbred SHR RatsInflammationInflammatoryInflammatory ResponseInjuryInnate Immune ResponseInnate Immune SystemInvestigationIschemiaKidneyKnowledgeLeadLinkMediator of activation proteinMetabolic stressMitochondriaMitochondrial DNAModelingMolecularMyelogenousNatriuresisNatural ImmunityNecrosisNeurosciencesNitric OxideOrganPathogenesisPathway interactionsPatternPattern recognition receptorPerfusionPericytesPeriodicityPeripheralPharmacologyPhenotypePhysiologicalPhysiologyPlayProductionReceptor ActivationRegulatory T-LymphocyteResearchResearch PersonnelRoleScientistSex CharacteristicsSignal TransductionT-Cell ActivationT-LymphocyteTLR4 geneTLR9 geneTestingTissuesToll-like receptorsVas OcclusionsVascular DiseasesVascular remodelingVasodilationadaptive immunityarterial stiffnessbaseblood pressure regulationcell injurycell typecollaborative approachendothelial dysfunctionexperimental studyhypertension treatmentimprovedimproved outcomeinjuredinstrumentationinterdisciplinary approachmalemenmonocyteneutrophilnew therapeutic targetnovelprematurepressurepreventprogramssexsynergismtargeted treatmenttooltranslational studytreatment groupvascular inflammationvasoconstrictionyoung woman
项目摘要
PROGRAM SUMMARY PROGRAM DIRECTOR, WEBB
The integrating theme and unifying hypothesis of this program project centers on the role played by damage-
associated-molecular patterns (DAMPs) in hypertension. DAMPs are alarm signals generated from injured
host cells, damaged tissues or metabolic stress and are recognized by the innate immune system. We
hypothesize that sustained activation of the innate immune system in hypertension is maladaptive, leading to
activation of circulating neutrophils and monocytes in the peripheral circulation, which home to the vasculature,
and cause increased tissue destruction and low-grade inflammation. These inflammatory events contribute to
increased vasoconstriction, vascular remodeling, and renal injury that occur under the action of initiating
factors to increase blood pressure. Project 1 will test the hypothesis that in hypertension, exaggerated
apoptosis and necrosis in the vascular wall give rise to mitochondrial DNA (mtDNA), a DAMP that activates
Toll-like receptor 9 (TLR9) causing vascular inflammation, vasoconstriction and endothelial dysfunction. In
Project 2, it is hypothesized that cell death induces high mobility group box 1 (HMGB1) release and TLR4
activation resulting in dentritic cell (DC) and T cell activation and increases in blood pressure in both sexes.
However, due to a sex difference in the type of cell death, the molecular pathway driving immune-based
hypertension in females favors greater T regulatory cell (Treg) formation. This hypothesis predicts that
necrosis results in greater HMGB1 release and TLR4 activation in males leading to myeloid DC activation of
Th17 cells and increases in blood pressure and end-organ damage relative to females, while greater apoptosis
in females limits HMGB1 release and activates plasmacytoid DC to increase Treg formation limiting increases
in blood pressure and injury relative to males. Project 3 tests the hypothesis that high circulating DAMPs
stimulate inappropriate nitric oxide (NO) production by vasa recta (VR) endothelial cells in low sheer states.
This NO production is detrimental as it inhibits spontaneous rhythmic contractions of VR pericytes that
normally act to prevent red blood cell aggregations under these conditions. RBC occlusion of the VR then
leads to rarefaction of the surrounding medullary vasculature, impaired pressure-natriuresis and hypertension.
These conceptually unique approaches, combined with novel technological tools will advance our
understanding of the molecular and physiological mechanisms underlying the initiation of vascular injury and
end organ damage of hypertension. All projects will use the spontaneously hypertensive rat as an animal
model. This highly integrative and collaborative approach of the three component projects is supported by an
Administrative Core (Core A), the Animal Use and Instrumentation Core (Core B) and the Bioinflammation
Core (Core C).
Webb董事
本项目的综合主题和统一假设集中在损害所起的作用上-
相关分子模式(DAMPs)。DAMP是由受伤人员产生的警报信号
宿主细胞、受损组织或代谢应激,并被先天免疫系统识别。我们
假设先天免疫系统在高血压中持续激活是不适应的,导致
激活外周循环中的循环中性粒细胞和单核细胞,它们归巢于脉管系统,
导致组织破坏和轻度炎症这些炎症事件有助于
血管收缩、血管重塑和肾损伤的增加,这些都是在引发
增加血压的因素。项目1将测试假设,在高血压,夸大
血管壁中的凋亡和坏死引起线粒体DNA(mtDNA),一种激活
Toll样受体9(TLR 9)引起血管炎症、血管收缩和内皮功能障碍。在
项目2,假设细胞死亡诱导高迁移率族蛋白1(HMGB 1)释放和TLR 4
激活导致树突状细胞(DC)和T细胞激活,并增加两种性别的血压。
然而,由于细胞死亡类型的性别差异,
女性中的高血压有利于更大的T调节细胞(Treg)形成。这一假说预测,
坏死导致男性中HMGB 1释放和TLR 4活化增加,导致骨髓DC活化,
Th 17细胞和增加血压和终末器官损伤相对于女性,而更大的细胞凋亡
在女性中限制HMGB 1释放并激活浆细胞样DC以增加Treg形成限制性增加
与男性相比,血压和受伤的几率更高。项目3测试了高循环DAMP的假设,
刺激低剪切状态下直小血管(VR)内皮细胞产生不适当的一氧化氮(NO)。
这种NO的产生是有害的,因为它抑制了VR周细胞的自发节律性收缩,
通常在这些条件下起到防止红细胞聚集的作用。红细胞阻塞VR,
导致周围髓血管的稀疏、压力-尿钠排泄受损和高血压。
这些概念上独特的方法,结合新的技术工具,将推动我们的
了解血管损伤启动的分子和生理机制,
高血压终末器官损害所有项目都将使用自发性高血压大鼠作为动物
模型这三个组成部分项目的高度整合和协作方法得到了
管理核心(核心A)、动物使用和工具核心(核心B)和生物炎症
核心(核心C)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
R Clinton Webb其他文献
Neurophysiological basis of penile erection
阴茎勃起的神经生理基础
- DOI:
10.1111/j.1745-7254.2007.00584.x - 发表时间:
2007-06-01 - 期刊:
- 影响因子:8.400
- 作者:
Fernanda B M Priviero;Romulo Leite;R Clinton Webb;Cleber E Teixeira - 通讯作者:
Cleber E Teixeira
Response to COVID-19 and ACEI/ARB: NOT ASSOCIATED?
对 COVID-19 和 ACEI/ARB 的回应:不相关?
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:3.2
- 作者:
E. Schiffrin;John M. Flack;S. Ito;P. Muntner;R Clinton Webb - 通讯作者:
R Clinton Webb
R Clinton Webb的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('R Clinton Webb', 18)}}的其他基金
Toll-like receptor 9 activation by mitochondrial DNA causes vascular injury in hypertension
线粒体 DNA 激活 Toll 样受体 9 导致高血压血管损伤
- 批准号:
10094229 - 财政年份:2017
- 资助金额:
$ 188.85万 - 项目类别:
TNF-alpha: a key player in erectile (dys)function
TNF-α:勃起(功能障碍)的关键因素
- 批准号:
7872961 - 财政年份:2009
- 资助金额:
$ 188.85万 - 项目类别:
TNF-alpha: a key player in erectile (dys)function
TNF-α:勃起(功能障碍)的关键因素
- 批准号:
8298246 - 财政年份:2009
- 资助金额:
$ 188.85万 - 项目类别:
TNF-alpha: a key player in erectile (dys)function
TNF-α:勃起(功能障碍)的关键因素
- 批准号:
7735745 - 财政年份:2009
- 资助金额:
$ 188.85万 - 项目类别:
TNF-alpha: a key player in erectile (dys)function
TNF-α:勃起(功能障碍)的关键因素
- 批准号:
8116051 - 财政年份:2009
- 资助金额:
$ 188.85万 - 项目类别:
Vascular RhoA/Rho-kinase Signaling in Angiotensin II-induced Hypertension
血管紧张素 II 诱导的高血压中的血管 RhoA/Rho 激酶信号转导
- 批准号:
7433779 - 财政年份:2007
- 资助金额:
$ 188.85万 - 项目类别:
Vascular Rho-kinase Signaling in Angiotensin II hyperten
血管紧张素 II 高血压中的血管 Rho 激酶信号转导
- 批准号:
7228247 - 财政年份:2006
- 资助金额:
$ 188.85万 - 项目类别:
Vascular Rho-kinase Signaling in Angiotensin II hyperten
血管紧张素 II 高血压中的血管 Rho 激酶信号转导
- 批准号:
7063186 - 财政年份:2005
- 资助金额:
$ 188.85万 - 项目类别:
Cytokines and angiotensin II-induced hypertension
细胞因子和血管紧张素 II 诱导的高血压
- 批准号:
7060929 - 财政年份:2004
- 资助金额:
$ 188.85万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 188.85万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 188.85万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 188.85万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 188.85万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 188.85万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 188.85万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 188.85万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 188.85万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 188.85万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 188.85万 - 项目类别:
Research Grant